MedTrace Logo

Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients

NCT03289494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2020-05-27

No results posted yet for this study

Summary

The study is a randomized cross-over pilot study. The research hypothesis is that the diet high in SDS content (H-SDS) will lower the daylong glycemic response and improve the glycemic control in patients with type 2 diabetes (T2D) compared to the diet low in SDS content (L-SDS).

Conditions

  • Type2 Diabetes

Interventions

OTHER

Balanced diet high in Slowly Digestible Starch

The carbohydrate present in the diet high in Slowly Digestible Starch were selected according to the general recommendations made for diabetics and according to their SDS content. The diet will be consumed during one week.

OTHER

Balanced diet low in Slowly Digestible Starch

The carbohydrate present in the diet low in Slowly Digestible Starch were selected according to the general recommendations made for diabetics and according to their SDS content. The diet will be consumed during one week.

Sponsors & Collaborators

  • Centre de Recherche en Nutrition Humaine Rhone-Alpe

    collaborator OTHER

  • Biofortis Mérieux NutriSciences

    collaborator OTHER

  • Mondelēz International, Inc.

    lead INDUSTRY

Principal Investigators

  • Emmanuel DISSE, MD, PhD · Centre de Recherche en Nutrition Humaine Rhône-Alpes

  • Martine LAVILLE, MD, PhD · Centre de Recherche en Nutrition Humaine Rhône-Alpes

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2018-07-24
Completion
2018-07-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03289494 on ClinicalTrials.gov